measles (lawoujol, rougeole)

measles (lawoujol, rougeole)

(In territories with significant traditional TRAMIL use)

Martinique:

  • malnommée
  • malomé
  • malomin

Haiti:

  • malnommée H
  • malomé H
  • malomin H

Cuba:

  • tapón
Significant uses found by the TRAMIL surveys

aerial parts, decoction, orally3

Recommendations Preparation and Dosage References

According to the information available:

The use for absé dlé (inguinal lymph node disease) and measles is classified as REC based on the significant traditional use documented in the TRAMIL surveys and the scientific information published.

All topical application must follow strict hygiene measures in order to prevent contamination or additional infection.

The use of this resource in cases of diarrhoea should be considered complementary to oral rehydration therapy.

The use of this resource for measles should be considered complementary for its antipyretic, immunostimulant, anti- inflammatory and antihistamine properties.

If deterioration is observed in the patient or if absé dlé (inguinal lymph node disease) persists for more than 8 days or the diarrhoea for more than 3 days in adults, 2 days in children over 3 years of age, seek medical attention.

Not for use during pregnancy, breastfeeding or in children under 3 years.

For absé dlé (inguinal ganglionic disease): wash 50 grams of leaves with abundant boiled water and crush. Place enough to cover the affected area, previously washed with boiled water and soap. Cover with a dressing or clean cloth and change every 8 hours.

For diarrhoea:
prepare a decoction with 40 grams of fresh aerial parts in 6 cups (1 1⁄2 litres) of water, boil in an open vessel and reduce by half. Cool, strain (filter) and drink 1 cup 3 times a day for 3 days33 .

For measles:
prepare a decoction with 30 grams of fresh aerial parts in 6 cups (1 1⁄2 litres) of water, boil in an open vessel and reduce to 1 litre. Cool, strain (filter) and drink 1 cup 3 times a day for 2 or 3 days33 .

Preparations must never be stored for more than 24 hours, even if refrigerated.

1 WENIGER B, ROUZIER M, 1986
Enquête TRAMIL. Service Oecuménique d'Entraide SOE, Port au Prince, Haïti.

2 CARBALLO A, 1990
Encuesta TRAMIL. Centro de investigación de fitoterapia y medicina tradicional de Topes de Collantes, Trinidad, Cuba.

3 LONGUEFOSSE JL, NOSSIN E, 1990-95
Enquête TRAMIL. Association pour la valorisation des plantes médicinales de la Caraïbe AVPMC, Fort de France, Martinique.

4 CHANDLER RF, HOOPER SN, 1979
Friedelin and associated triterpenoids. Phytochemistry 18:711-724.

5 HALLETT FP, PARKS LM, 1951
A note on the isolation of quercitrin from Euphorbia pilulifera, L. J Amer Pharm Assoc 40(1):56-57.

6 GALVEZ J, ZARZUELO A, CRESPO ME, LORENTE MD, OCETE MA, JIMÉNEZ J, 1993
Antidiarrhoeic activity of Euphorbia hirta extract and isolation of an active flavonoid constituent. Planta Med 59(4):333-336.

7 UEDA H, CHIAO-MU H, 1949
A chemical study of Euphorbia. J Taiwan Pharm Assoc 1:40-43.

8 HILL JS, 1909
Preliminary examination of Euphorbia pilulifera. Pharm J 83:141-142.

9 YOSHIDA T, CHEN L, SHINGU T, OKUDA T, 1988
Tannins and related polyphenols of euphorbiaceous plants. IV. Euphorbins A and B, novel dimeric dehydroellagitannins from Euphorbia hirta L. Chem Pharm Bull 36(8):2940-2949.

10 YOSHIDA T, NAMBA O, CHEN L, OKUDA T, 1990
Tannins and related polyphenols of euphorbiaceous plants. V. Euphorbin C, an equilibrated dimeric dehydroellagitannin having a new tetrameric galloyl group. Chem Pharm Bull 38(1):86-93.

11 YOSHIDA T, NAMBA O, CHEN L, OKUDA T, 1990
Euphorbin E, a hydrolyzable tannin dimer of highly oxidized structure, from Euphorbia hirta. Chem Pharm Bull 38(4):1113-1115.

12 RAO CV, GANAPATY S, 1983
Investigation on Euphorbia pilulifera L. Fitoterapia 54(6):265-267.

13 NORDAL A, KROGH A, OGNER G, 1965
The occurrence of phorbic acid in plants. Acta Chem Scand 19(7):1705-1708.

14 GUPTA DR, GARG SK, 1966
A chemical examination of Euphorbia hirta. Bull Chem Soc Japan 39(11):2532-2534.

15 BASLAS RK, AGARWAL R, 1980
Chemical investigation of some anticancer plants of Euphorbia genus. Indian J Chem Ser B 19:717-718.

16 BASLAS RK, AGARWAL R, 1980
Isolation and characterization of different constituents of Euphorbia hirta Linn. Curr Sci 49:311-312.

17 POWER FB, BROWNING JRH, 1914
Chemical examination of Euphorbia pilulifera. Pharm J 90:506-510.

18 BLANC P, DE SAQUISANNES G, 1972
Flavonoids of Euphorbia hirta. Plant Med Phytother 6(2):106-109.

19 EL-NAGGAR L, BEAL JL, PARKS LM, SALMAN KN, PATIL P, SCHWARTING AE, 1978
A note on the isolation and identification of two pharmacologically active constituents of Euphorbia pilulifera. Lloydia 41(1):73-75.

20 HUSSAIN H, DEENI Y, 1991
Plants in Kano ethomedicine; screening for antimicrobial activity and alkaloids. Int J Pharmacog 29(1):51-56.

21 BASHIR AK, HASSAN ESS, AMIRI MH, ABDALLA AA, WASFI IA, 1992
Antimicrobial activity of certain plants used in the folk-medicine of United Arab Emirates. Fitoterapia 63(4):371-375.

22 GLELE-COEFE J, SENET JM, 1982
Study of the influence of water soluble extracts on the growth of Entamoeba histolytica in axenic medium in vitro. Plant Med Phytother 16:122-128.

23 DHAR ML, DHAR MM, DHAWAN BN, MEHROTRA BN, RAY C, 1968
Screening of Indian plants for biological activity: part I. Indian J Exp Biol 6:232-247.

24 AJAO AO, EMELE F, FEMI ONADEKO B, 1985
Antibacterial activity of Euphorbia hirta. Fitoterapia 56(3):165-167.

25 SINGH J, DUBEY AK, TRIPATHI NN, 1994
Antifungal activity of Mentha spicata. Int J Pharmacog 32(4):314-319.

26 HAZLETON LW, HELLERMAN RC, 1948
Studies on the pharmacology of Euphorbia pilulifera. J Amer Pharm Ass Sci Ed 37:491.

27 FENG PC, HAYNES LJ, MAGNUS KE, PLIMMER JR, SHERRAT HSA, 1962
Pharmacological screening of some West Indian medicinal plants. J Pharm Pharmacol 14:556-561.

28 HIERMANN A, BUCAR F, 1994
Influence of some traditional medicinal plants of Senegal on prostaglandin biosynthesis. J Ethnopharmacol 42(2):111-116.

29 LANHERS MC, FLEURENTIN J, DORFMAN P, MORTIER F, PELT JM, 1991
Analgesic, antipyretic and anti-inflammatory properties of Euphorbia hirta. Planta Med 57(3):225-231.

30 KINGHORN AD, EVANS FJ, 1975
A biological screen of selected species of the genus Euphorbia for skin irritant effects. Planta Med 28:325-335.

31 LANHERS MC, FLEURENTIN J, CABALION P, ROLLAND A, DORFMAN P, MISSLIN R, PELT JM, 1990
Behavioral effects of Euphorbia hirta L.: Sedative and anxiolytic properties. J Ethnopharmacol 29(2):189-198.

32 MOKKHASMIT M, SWATDIMONGKOL K, SATRAWAHA P, 1971
Study on toxicity of Thai medicinal plants. Bull Dept Med Sci 12(2/4):36-65.

33 LONGUEFOSSE JL, 1995
100 Plantes médicinales de la Caraïbe. Guadeloupe: Gondwana Editions. p153.